Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
CAMTEK LTD.
(Translation of
Registrants Name into English)
Ramat Gavriel Industrial Zone
P.O. Box 544
Migdal Haemek 23150
ISRAEL
(Address of Principal Corporate Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities and Exchange Act of 1934.
Yes o No x
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CAMTEK LTD. (Registrant) By: /s/ Ronit Dulberg Ronit Dulberg, Chief Financial Officer |
Dated: February 20, 2008
Camtek Ltd.
P.O.Box 544, Ramat Gabriel Industrial Park Migdal Ha'Emek 23150, ISRAEL Tel: +972 (4) 604-8100 Fax: +972 (4) 644-0523 E-Mail: Info@camtek.co.il Web site: http://www.camtek.co.il |
20-2-07
FOR IMMEDIATE RELEASE
CAMTEK ANNOUNCES 2007 FOURTH QUARTER
AND FULL YEAR RESULTS
Sequential growth in revenues and profitability
MIGDAL HAEMEK, Israel February 20, 2008 Camtek Ltd. (NASDAQ and TASE: CAMT), today announced results for the fourth quarter and year ended December 31, 2007.
The Company reported revenues for the fourth quarter of 2007 of $21.0 million, equivalent to the $21.0 million reported in the fourth quarter of 2006, and an increase of 4% sequentially from $20.1 million in the third quarter of 2007.
Gross profit margin for the fourth quarter of 2007 was 43.7%, as compared to 44.5% for the fourth quarter of 2006, and 37.6% for the third quarter of 2007.
Income before tax for the fourth quarter of 2007 was $0.2 million. This compares to a loss before tax of $2.5 million in the fourth quarter of 2006. For the previous quarter in 2007, income before tax was $0.2 million.
Interpretation No. 48, Accounting for Uncertainty in Income Taxes-an interpretation of FASB Statement No. 109 (FIN 48), was effective for the Company, for the first time, in fiscal year 2007. The Company has not yet completed a thorough review of the application of FIN 48 as it relates to its subsidiaries abroad for the determination of its effects, if any, on its results of operations and financial position. The Company will, if necessary, issue a supplemental press release following the completion of its analysis of the effects of FIN 48 to report any material adjustment to its net loss and loss per share for the year ended December 31, 2007.
Net income (without impact of FIN 48 review) for the fourth quarter of 2007 was $0.3 million, or $0.01 per diluted share. This compares to a net loss of $2.2 million, or $0.07 per diluted share, in the fourth quarter of 2006. For the previous quarter in 2007, net income (without impact of FIN 48 review) was $87 thousand, or $0.00 per diluted share.
The Company reported a positive operating cash flow of $2.7 million in the fourth quarter.
Revenues for the year ended December 31, 2007, were $71.0 million, a decrease of 29% from $100.1 million reported for the year ended December 31, 2006. Gross profit margin for 2007 was 40.9%, compared to 51.6% in 2006. Net loss (without impact of FIN 48 review) for the year ended December 31, 2007 was $7.5 million, or $0.25 per diluted share, compared to a net income of $11.6 million, or $0.39 per diluted share, for the year ended December 31, 2006.
The fourth quarter continued and built on the positive trend that we resumed in the third quarter. We are very pleased to present much improved margins and a positive cash flow, commented Rafi Amit, Camteks CEO. We are seeing an increase in demand for our systems for the semiconductor manufacturing and packaging industry, and we believe this is very sustainable going forward. Our sales to the PCB industry have remained solid throughout the second half of the year, and we see it as indicative of the warm acceptance of our new generation of products as well as the strengthening of our competitive position in this market.
Mr. Amit continued, In line with our long-term strategy, we are maintaining our on-going R&D investment in continually enhancing our products to deliver increasing value to our customers. In 2007 we enhanced the Falcon line with even higher throughput and detection ability and introduced a new generation of AOI and Verification systems to the PCB market. In 2008, we plan to introduce additional products and expand our market coverage.
Mr. Amit concluded, Assuming that the stream of incoming orders from the semiconductors and PCB industries remains in its current course, we expect revenues for the first quarter of 2008 to come at a similar level to that we reported today.
Camtek will host a conference call today, February 20, at 9:00am ET. Rafi Amit, Chief Executive Officer, and Ronit Dulberg, Chief Financial Officer will host the call and will be available to answer questions after presenting the results.
To participate, please call one of the following telephone numbers at least 10 minutes before the start of the call, referencing the Camtek fourth quarter 2007 results conference call.
US toll free: | 1 888 935 4577 | at 9:00 a.m. Eastern Time |
Israel toll free: | 1 809 246 002 | at 4:00 p.m. Israel Time |
International: | +1 718 354 1389 |
For those unable to participate, the teleconference will be available for replay on Camteks website www.camtek.co.il beginning 24 hours after the call.
ABOUT CAMTEK LTD.
With headquarters in Migdal
HaEmek Israel, Camtek Ltd., designs, develops, manufactures, and markets automatic
optical inspection systems and related products. Camteks automatic inspection
systems are used to enhance both production processes and yield for manufacturers in the
printed circuit board industry, the high density interconnect substrate industry and the
semiconductor manufacturing and packaging industry.
This press release is available at
www.camtek.co.il
Contact Details | |
|
|
CAMTEK | IR INTERNATIONAL |
Ronit Dulberg, CFO | GK International IR |
Tel: +972-4-604-8308 | Ehud Helft / Kenny Green |
Fax: +972-4-604 8300 | Tel: (US) 1 646 201 9246 |
Mobile: +972-54-9050776 | info@gkir.com |
ronitd@camtek.co.il |
This press release may contain projections or other forward-looking statements regarding future events or the future performance of the Company. These statements are only predictions and may change as time passes. We do not assume any obligation to update that information. Actual events or results may differ materially from those projected, including as a result of changing industry and market trends, reduced demand for our products, the timely development of our new products and their adoption by the market, increased competition in the industry, price reductions as well as due to risks identified in the documents filed by the Company with the SEC.
Consolidated Balance Sheets |
(in thousands, except share data) |
December |
December | |||||||
---|---|---|---|---|---|---|---|---|
2007 |
2006 | |||||||
U.S. Dollars |
||||||||
ASSETS | ||||||||
CURRENT ASSETS | ||||||||
Cash and cash equivalents | 18,601 | 23,358 | ||||||
Marketable securities | 1,395 | 2,099 | ||||||
Accounts receivable, net | 23,500 | 29,434 | ||||||
Inventories | 34,243 | 41,414 | ||||||
Due from affiliates | 251 | 180 | ||||||
Other current assets | 2,623 | 2,372 | ||||||
Deferred tax | 65 | 65 | ||||||
Total current assets | 80,678 | 98,922 | ||||||
Fixed assets, net | 15,325 | 10,729 | ||||||
Marketable securities | 1,075 | - | ||||||
Deferred tax | 380 | 369 | ||||||
Other assets | 993 | 786 | ||||||
2,448 | 1,155 | |||||||
Total assets | 98,451 | 110,806 | ||||||
LIABILITIES | ||||||||
CURRENT LIABILITIES | ||||||||
Accounts payable -trade | 7,960 | 11,801 | ||||||
Due to affiliates | 866 | 814 | ||||||
Other current liabilities | 11,233 | 12,831 | ||||||
Total current liabilities | 20,059 | 25,446 | ||||||
Convertible loan | 5,000 | 5,000 | ||||||
Liability for employee severance benefits | 268 | 222 | ||||||
Total liabilities | 25,327 | 30,668 | ||||||
SHAREHOLDERS' EQUITY | ||||||||
Ordinary shares NIS 0.01 par value, authorized 100,000,000 shares, | ||||||||
issued 31,145,334 in 2007 and 31,052,474 in 2006, outstanding | ||||||||
30,133,715 in 2007 and 30,040,855 in 2006. | 132 | 132 | ||||||
Additional paid-in capital | 59,878 | 59,420 | ||||||
Accumulated other comprehensive loss | ||||||||
Unrealized loss on marketable securities | - | (1 | ) | |||||
Retained earnings | 14,107 | 21,580 | ||||||
74,117 | 81,131 | |||||||
Treasury stock, at cost (1,011,619 shares in 2007 and 2006) | (993 | ) | (993 | ) | ||||
Total shareholders' equity | 73,124 | 80,138 | ||||||
Total liabilities and shareholders' equity | 98,451 | 110,806 | ||||||
Note: Without impact of FIN 48 review
Consolidated Statements of Operations |
(in thousands, except share data) |
Three Months ended December 31, |
Year ended December 31, |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2007 |
2006 |
2007 |
2006 | |||||||||||
U.S. dollars |
U.S. dollars |
|||||||||||||
Revenues | 21,028 | 21,006 | 70,969 | 100,055 | ||||||||||
Cost of revenues | 11,841 | 11,666 | 41,940 | 48,442 | ||||||||||
Gross profit | 9,187 | 9,340 | 29,029 | 51,613 | ||||||||||
Research and development costs | 2,963 | 3,662 | 12,111 | 11,831 | ||||||||||
Selling, general and administrative expenses | 6,098 | 8,120 | 24,119 | 27,850 | ||||||||||
9,061 | 11,782 | 36,230 | 39,681 | |||||||||||
Operating income (loss) | 126 | (2,442 | ) | (7,201 | ) | 11,932 | ||||||||
Financial income (expenses), net | 66 | (115 | ) | (128 | ) | (288 | ) | |||||||
Income (loss) before income taxes | 192 | (2,557 | ) | (7,329 | ) | 11,644 | ||||||||
Income tax | 55 | 333 | (144 | ) | (41 | ) | ||||||||
Net income (loss) | 247 | (2,224 | ) | (7,473 | ) | 11,603 | ||||||||
Net income (loss) per ordinary share: | ||||||||||||||
Basic | 0.01 | (0.07 | ) | (0.25 | ) | 0.40 | ||||||||
Diluted | 0.01 | (0.07 | ) | (0.25 | ) | 0.39 | ||||||||
Weighted average number of ordinary | ||||||||||||||
shares outstanding: | ||||||||||||||
Basic | 30,212 | 30,200 | 30,145 | 29,176 | ||||||||||
Diluted | 30,212 | 30,200 | 30,145 | 29,553 | ||||||||||
Note: Without impact of FIN 48 review